Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

DIVA test discovered to detect Johne's disease in goats
"This will support the use of vaccines as part of MAP control programs" - Professor Cath Rees.

Actiphage can differentiate between vaccinated and infected animals.

A new diagnostic test has shown potential to differentiate between vaccinated and infected animals with Johne's disease.

Previously, vaccination of livestock against Johne's disease, an infectious wasting condition affecting ruminants, has been hindered because there is no diagnostic test that can differentiate between vaccinated animals, and those with the disease (DIVA test). 

Researchers have discovered that the Actiphage blood test can differentiate between goats that are naturally infected with Johne's disease, and those with vaccinations. 

This discovery suggests potential for a vaccination programme to protect ruminants from the usually fatal disease. While previous tests to detect infection in vaccinated goats did not work, Actiphage detects live bacteria in a milk or blood sample. Because of this, the test is not affected by vaccination status. 

Professor Cath Rees, from the University of Nottingham, said: “We have now shown that Actiphage is compatible with a range of different methods for purifying white blood cells, demonstrating the versatility of our test and opening up a number of new applications.”

“This study provides evidence that Actiphage can also be used as a DIVA test, allowing us to differentiate between naturally infected and vaccinated animals; this will support the use of vaccines as part of MAP (Mycobacterium avium subspecies paratuberculosis) control programs.”

 

Image (C) PBD Biotech

Become a member or log in to add this story to your CPD history

Submissions open for BSAVA Clinical Research Abstracts 2026

News Story 1
 The BSAVA has opened submissions for the BSAVA Clinical Research Abstracts 2026.

It is an opportunity for applicants to present new research on any veterinary subject, such as the preliminary results of a study, discussion of a new technique or a description of an interesting case.

They must be based on high-quality clinical research conducted in industry, practice or academia, and summarised in 250 words.

Applications are welcome from vets, vet nurses, practice managers, and students.

Submissions are open until 6 March 2026. 

Click here for more...
News Shorts
Survey seeks ruminant sector views on antimicrobial stewardship

A new survey is seeking views of people working in the UK ruminant sector on how to tackle the challenge of demonstrating responsible antibiotic stewardship.

Forming part of a wider, collaborative initiative, the results will help identify the types of data available so that challenges with data collection can be better understood and addressed.

Anyone working in the UK farming sector, including vets and farmers,is encouraged to complete the survey, which is available at app.onlinesurveys.jisc.ac.uk